Cryopreservation using sucralose
Inventors
Kennedy, Anthony • Scemama, Jean-Luc • Virag, Jitka • Pennington, Edward R.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Embodiments of the present invention relate to methods of preparing a cell, tissue, organ or plant for cryopreservation, wherein the method includes contacting the cell, tissue, organ or plant with a composition including sucrose and/or sucralose.
Core Innovation
The patent describes sucrose and sucralose in cryopreservation as a means of reducing membrane-associated ice formation and cell death. The problem addressed is damage associated with ice crystal formation during cryogenic exposure or freezing. The described methods are directed to cells, tissues, organs, and plants, with the claims specifically reciting contacting targets with a sucralose-containing composition and subjecting them to cryogenic temperatures.
The document reports that sucralose alters DPPC membrane phase behavior and displaces water near membranes. Red-blood-cell experiments report reduced post-freeze hemolysis, with protection reported as greater than glycerol in comparative testing. Furthermore, figure summaries report that sucralose generally reduces red-blood-cell hemolysis relative to untreated controls. These findings are presented in connection with reducing ice formation and cell death during cryopreservation.
Claims Coverage
The claims recite three inventive features directed to cryopreservation using sucralose, reduction of ice crystal formation, and reduction of cell death during cryopreservation across cells, tissues, organs, or plants.
Sucralose-based cryopreservation
Claim 1 covers cryopreservation of a cell, tissue, organ, or plant using a sucralose-containing composition. The claimed composition details and freezing procedure are [procedural detail omitted for safety]. Dependent claims identify red blood cells and tomato plants as particular targets.
Reduction of ice crystal formation
Claim 5 covers reducing ice crystal formation in a cell, tissue, organ, or plant through use of a sucralose-containing composition during cryogenic exposure. The claimed composition details and procedure are [procedural detail omitted for safety].
Reduction of cell death during cryopreservation
Claim 6 covers reducing cell death in a cell, tissue, organ, or plant during cryopreservation by contacting the target with a sucralose-containing composition and subjecting it to cryogenic temperatures; [procedural detail omitted for safety].
All elements of the claim across the independent claims cover sucralose-based cryopreservation, reduction of ice crystal formation, and reduction of cell death for cells, tissues, organs, and plants.
Stated Advantages
The document describes reducing membrane-associated ice crystal formation and cell death during cryopreservation.
Red-blood-cell experiments report reduced post-freeze hemolysis, with protection reported as greater than glycerol in a comparison.
A dependent claim describes improved cryopreservation compared with methods using glycerol or dimethylsulfoxide.
The supplied figure summary reports that sucralose generally reduces red-blood-cell hemolysis relative to an untreated control.
Documented Applications
Cryopreservation of cells, tissues, and organs, including preparations intended for transfusion or transplantation.
Cryopreservation of plants, including tomato plants.
Cryopreservation of red blood cells.
Interested in licensing this patent?